Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing. Wound Contact Layers (WCLs) are a type of non-adherent dressings used to protect wounds with fragile tissue and periwound skin. GlobalData uses proprietary data and analytics to provide a comprehensive report on the wound contact layers devices market, including market shares of different players within Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the wound contact layers market in Australia was Molnlycke Health Care followed by Smith & Nephew, 3M, Coloplast, Medline Industries, Urgo and B. Braun Melsungen.
A WCL can be made up of either woven or non-woven material. They can be directly applied to the wound. WCLs are perforated/permeable and allow exudates to pass through secondary dressings. Benefits of contact layers are that they are specifically designed to stay on the wound bed for several days without disrupting the growth of new tissue and to protect the wound bed during dressing changes. This effectively reduces trauma and pain during the dressing changes and promotes healing process. Antimicrobial WCL and Non-Antimicrobial WCL are tracked under this segment. Antimicrobial WCLs are types of WCLs which have an antiseptic agent incorporated to reduce the risk of bacterial growth and other microbes, such as fungi and viruses, on the wound and surrounding skin. Non-Antimicrobial WCLs are contact layers with no antiseptic agent coated on them.
The value of the wound contact layers devices market within Australia was expected to be over $8m in 2023.
For the latest complete market share analysis of wound contact layers device market in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
